Health Catalyst (NASDAQ: HCAT) director plans sale of 6,614 shares

Rhea-AI Filing Summary

Health Catalyst insider sale notice. A Form 144 filing dated 02/26/2026 indicates a proposed sale of 6,614 shares of common stock (restricted stock) of Health Catalyst, Inc. through Morgan Stanley Smith Barney LLC. The filing also discloses prior sales of 16,401 shares on 12/01/2025 for $47,566.18.

Insights

Corporate Governance Analyst

Routine insider selling disclosed via Form 144; no material company-side event.

The filing lists a proposed sale of 6,614 restricted shares scheduled 02/26/2026 and prior reported sales of 16,401 shares on 12/01/2025 for $47,566.18. The transaction is reported through Morgan Stanley Smith Barney LLC.

Such notices document intended transfers by a holder; the filing alone does not state execution, price per share, or proceeds recipient beyond the broker record. Subsequent transaction confirmations or amended filings will show whether the listed sales were completed.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th Floor New York NY 10004	6614	11559.95	70730884	02/26/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/26/2026	Restricted Stock	Health Catalyst, Inc.			6614	02/26/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kevin Freeman c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	12/01/2025	16401	47566.18

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the Health Catalyst (HCAT) Form 144 disclose?

The Form 144 discloses a proposed sale of 6,614 restricted common shares scheduled 02/26/2026. It also reports prior sales of 16,401 shares on 12/01/2025 for $47,566.18.

Who is the broker handling the proposed sale for HCAT?

The filing lists Morgan Stanley Smith Barney LLC at 1 New York Plaza as the broker for the reported transaction. The broker name appears next to the listed proposed sale of 6,614 shares on 02/26/2026.

Does this Form 144 confirm the shares were sold?

No; the Form 144 reports a proposed sale and prior sales but does not confirm execution. The filing shows an intended sale of 6,614 shares on 02/26/2026, while earlier sales on 12/01/2025 are recorded as completed in the past three months.

How much did the prior insider sales generate according to the filing?

The filing reports prior sales of 16,401 shares on 12/01/2025 with an aggregate amount of $47,566.18. The document lists the prior-sales figures alongside the proposed sale details for 02/26/2026.